Effect of Short-Chain Fatty Acids and Polyunsaturated Fatty Acids on Metabolites in H460 Lung Cancer Cells
Molecules · 2023
DOI: 10.3390/molecules28052357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Tianxiao Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Science and Technology Commission Scientific Research Project.
Abstract (Originalsprache)
Lung cancer is the most common primary malignant lung tumor. However, the etiology of lung cancer is still unclear. Fatty acids include short-chain fatty acids (SCFAs) and polyunsaturated fatty acids (PUFAs) as essential components of lipids. SCFAs can enter the nucleus of cancer cells, inhibit histone deacetylase activity, and upregulate histone acetylation and crotonylation. Meanwhile, PUFAs can inhibit lung cancer cells. Moreover, they also play an essential role in inhibiting migration and invasion. However, the mechanisms and different effects of SCFAs and PUFAs on lung cancer remain unclear. Sodium acetate, butyrate, linoleic acid, and linolenic acid were selected to treat H460 lung cancer cells. Through untargeted metabonomics, it was observed that the differential metabolites were concentrated in energy metabolites, phospholipids, and bile acids. Then, targeted metabonomics was conducted for these three target types. Three LC-MS/MS methods were established for 71 compounds, including energy metabolites, phospholipids, and bile acids. The subsequent methodology validation results were used to verify the validity of the method. The targeted metabonomics results show that, in H460 lung cancer cells incubated with linolenic acid and linoleic acid, while the content of PCs increased significantly, the content of Lyso PCs decreased significantly. This demonstrates that there are significant changes in LCAT content before and after administration. Through subsequent WB and RT-PCR experiments, the result was verified. We demonstrated a substantial metabolic disparity between the dosing and control groups, further verifying the reliability of the method.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID-Profile: Tianxiao Zhou, Yan Wang
Förderung
- National Natural Science Foundation of China
- Shanghai Science and Technology Commission Scientific Research Project
Zitieren
APA
Zhou, T., Yang, K., Huang, J., Fu, W., Yan, C., & Wang, Y. (2023). Effect of Short-Chain Fatty Acids and Polyunsaturated Fatty Acids on Metabolites in H460 Lung Cancer Cells. Molecules. https://doi.org/10.3390/molecules28052357
Vancouver
Zhou T, Yang K, Huang J, Fu W, Yan C, Wang Y. Effect of Short-Chain Fatty Acids and Polyunsaturated Fatty Acids on Metabolites in H460 Lung Cancer Cells. Molecules. 2023. doi:10.3390/molecules28052357
BibTeX
@article{Zhou2023,
author = {Zhou, Tianxiao and Yang, Kaige and Huang, Jin and Fu, Wenchang and Yan, Chao and Wang, Yan},
title = {Effect of Short-Chain Fatty Acids and Polyunsaturated Fatty Acids on Metabolites in H460 Lung Cancer Cells},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28052357}
}
EUVIMED